Texas Capital Bancshrs Pref Share TCBIO 5.75 Perp 06/15/26 B | 8-K: FY2025 Q2 EPS: USD 1.58

EPS: As of FY2025 Q2, the actual value is USD 1.58.

EBIT: As of FY2025 Q2, the actual value is USD 102.19 K.

Segment Revenue

• Total Revenue: $307.5 million in Q2 2025, compared to $267.0 million in Q2 2024, showing an increase driven by improved capital markets and sales and trading fees.

Operational Metrics

• Net Income: $77.3 million in Q2 2025, up from $42.0 million in Q2 2024.
• Return on Average Assets: 0.99% in Q2 2025, compared to 0.57% in Q2 2024.
• Efficiency Ratio: 61.9% in Q2 2025, compared to 70.4% in Q2 2024, indicating improved operational efficiency.

Cash Flow

• Net Interest Income: Increased to $253.4 million in Q2 2025 from $216.6 million in Q2 2024, supported by continued LHI growth and reduced funding costs.

Unique Metrics

• Treasury Product Fees: Increased to $11.6 million, marking the fourth consecutive record quarter.
• Assets Under Management: Increased 8% quarter-over-quarter to $4.1 billion, driven by accelerated client adoption of the improved platform.

Outlook / Guidance

• Texas Capital Bancshares, Inc. anticipates delivering durable, through-cycle results for both clients and shareholders, supported by the strength of its balance sheet and breadth of capabilities as it enters the second half of the year.
• The company expects low double-digit percentage growth in total revenue for the full year 2025, with a mid to high single-digit percentage growth in non-interest expense.
• The CET1 ratio target remains unchanged, and the tax rate is expected to be approximately 25% for the full year 2025. The company aims to achieve a quarterly return on average assets of 1.10% in the second half of 2025.